Table III.
Quantitative results of immunohistochemical analysis in metastatic and non-metastatic osteosarcoma specimens.
| Expression level | |||||
|---|---|---|---|---|---|
| Marker | Tissue | Low | Medium | High | Median score |
| CD56 | Metastatic | 11 | 3 | 2 | 2 |
| Non-metastatic | 1 | 4 | 13 | 5 | |
| CD22 | Metastatic | 10 | 2 | 4 | 2 |
| Non-metastatic | 2 | 1 | 15 | 5 | |
| CD86 | Metastatic | 12 | 2 | 2 | 2 |
| Non-metastatic | 3 | 2 | 13 | 5 | |
| CD163 | Metastatic | 3 | 1 | 12 | 5 |
| Non-metastatic | 15 | 1 | 2 | 2 | |
| CD11B | Metastatic | 10 | 5 | 1 | 2 |
| Non-metastatic | 2 | 5 | 11 | 5 | |
| GATA3 | Metastatic | 13 | 1 | 2 | 2 |
| Non-metastatic | 1 | 1 | 16 | 5 | |
| LPAR5 | Metastatic | 10 | 3 | 3 | 2 |
| Non-metastatic | 3 | 2 | 13 | 5 | |
| EVI2B | Metastatic | 14 | 2 | 0 | 1 |
| Non-metastatic | 3 | 3 | 12 | 5 | |
| RIAM | Metastatic | 11 | 3 | 2 | 2 |
| Non-metastatic | 3 | 2 | 13 | 5 | |
| CFH | Metastatic | 11 | 4 | 1 | 2 |
| Non-metastatic | 1 | 2 | 15 | 5 | |